Scientific Publication

Non-response to first-line anti-tuberculosis treatment in Sikkim, India: a risk-factor analysis study

author(s) Singhi L, . - Sagili, K.D.. - Sharath, B.N.. - Bhandari, K.
from UK Foreign, Commonwealth & Development Office (FCDO)
permalink open
themes
regions
  • Northern Europe
  • Europe
  • World
  • Southern Asia
  • Asia
citation

Singhi L, Sagili KD, Sharath BN, Bhandari K, Dadul PK, Gautam M, Ravichandra C, Chadha S, Satyanarayana S. Non-response to first-line anti-tuberculosis treatment in Sikkim, India: a risk-factor analysis study. Public Health Action. 2018 Dec 21;8(4):162–8

Publications and datasets provided via GARDIAN

Abstract

Sikkim, India, has the highest proportion of tuberculosis (TB) patients on first-line anti-tuberculosis regimens with the outcome ‘failure’ or ‘shifted to regimen for multidrug-resistant TB (MDR-TB)’. This article aims to assess the factors associated with non-response to treatment, i.e., ‘failure’ or ‘shifted to MDR-TB regimen’. This research was supported by the UK Department for International Development’s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)

Open original